Congratulations to Myeshia Shelby, whose project won the Public's Choice vote! Check out the article about the contest here, which includes interviews with multiple award winners.
Therapeutic Treatments for Cancer: Fostering a Dialogue Within a Faith Community
This project consisted of a presentation and dialogue with a faith community on the possibility of inhibiting cell proliferation during the metastatic stages of cancer as a means of therapeutic intervention. The research focuses on Topoisomerase I (TopI) inhibition by way of LMP744 drug treatment on cancerous cell lines.
Topoisomerases are a class of enzymes that assist with DNA transcription and replication. LMP744 is a drug that inhibits this process for type 1 topoisomerases, or TopI.
